As of 2025-09-08, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (15.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -199.7%.
The range of the Relative Valuation is (15.18) - (15.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.7x | 19.8x |
| Forward P/E multiples | 20.5x - 22.4x | 21.3x |
| Fair Price | (15.18) - (15.31) | (15.20) |
| Upside | -199.5% - -200.4% | -199.7% |
| Date | P/E |